Becton Dickinson & Co (BDX)
227.11
-12.95
(-5.39%)
USD |
NYSE |
Nov 07, 16:00
227.40
+0.29
(+0.13%)
After-Hours: 20:00
Becton Dickinson Revenue (Annual): 19.37B for Sept. 30, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
September 30, 2023 | 19.37B |
September 30, 2022 | 18.87B |
September 30, 2021 | 19.13B |
September 30, 2020 | 16.07B |
September 30, 2019 | 17.29B |
September 30, 2018 | 15.98B |
September 30, 2017 | 12.09B |
September 30, 2016 | 12.48B |
September 30, 2015 | 10.28B |
September 30, 2014 | 8.446B |
September 30, 2013 | 8.054B |
September 30, 2012 | 7.708B |
September 30, 2011 | 7.584B |
September 30, 2010 | 7.124B |
September 30, 2009 | 6.987B |
September 30, 2008 | 7.075B |
September 30, 2007 | 6.360B |
September 30, 2006 | 5.738B |
September 30, 2005 | 5.415B |
September 30, 2004 | 4.935B |
Date | Value |
---|---|
September 30, 2003 | 4.464B |
September 30, 2002 | 3.960B |
September 30, 2001 | 3.754B |
September 30, 2000 | 3.618B |
September 30, 1999 | 3.418B |
September 30, 1998 | 3.117B |
September 30, 1997 | 2.810B |
September 30, 1996 | 2.770B |
September 30, 1995 | 2.712B |
September 30, 1994 | 2.560B |
September 30, 1993 | 2.465B |
September 30, 1992 | 2.365B |
September 30, 1991 | 2.172B |
September 30, 1990 | 2.013B |
September 30, 1989 | 1.812B |
September 30, 1988 | 1.709B |
September 30, 1987 | 1.582B |
September 30, 1986 | 1.312B |
September 30, 1985 | 1.144B |
September 30, 1984 | 1.127B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
16.07B
Minimum
2020
19.37B
Maximum
2023
18.36B
Average
19.00B
Median
Revenue (Annual) Benchmarks
Boston Scientific Corp | 14.24B |
Moderna Inc | 6.754B |
Abbott Laboratories | 40.11B |
Eli Lilly and Co | 34.12B |
Merit Medical Systems Inc | 1.257B |